Magnesium%2525252525252525252525252525252525252525252525252525252525252520sulphate

# Magnesium Sulphate ## Overview Magnesium sulphate is an essential mineral that plays a role in numerous physiological processes. It is available in injectable and oral formulations. ## Primary Indications * **Hypomagnesemia:** Treatment of low magnesium levels. * **Eclampsia/Preeclampsia:** Prevention and treatment of seizures associated with severe preeclampsia and eclampsia. * **Torsades de Pointes:** Treatment of polymorphic ventricular tachycardia (Torsades de Pointes). * **Bronchodilator:** Adjunctive therapy in severe asthma exacerbations refractory to standard treatment. * **Laxative (Oral):** Relief of occasional constipation. ## Adult Dosing * **Hypomagnesemia:** * **Severe (symptomatic):** 4-5 g IV infusion over 5-10 minutes, followed by 1-2 g/hour IV infusion for up to 24 hours. Maintenance doses may be needed based on serum magnesium levels. * **Mild/Moderate (asymptomatic):** 1-2 g IM or IV infusion every 4-6 hours for 3-4 doses. * **Oral:** 30-40 mEq (240-320 mg elemental magnesium) daily in divided doses. * **Eclampsia/Preeclampsia:** * **Loading Dose:** 4-6 g IV infusion over 5-10 minutes. * **Maintenance Dose:** 1-2 g/hour IV infusion. If seizures recur, administer an additional 2-4 g IV bolus over 5 minutes. Dosing is often guided by local protocols and patient response. * **Torsades de Pointes:** 1-2 g IV infusion in 10 mL D5W over 5-10 minutes. May repeat bolus. Subsequent infusion of 0.5-1 g/hour may be used. * **Asthma:** 1-2 g IV infusion over 15-20 minutes. ## Pediatric Dosing Dosing in children is highly variable and dependent on indication, age, and weight. Specific dosing should be guided by expert consensus or local protocols. * **Hypomagnesemia:** Typically dosed based on weight, e.g., 25-50 mg/kg/dose IV infused over 5-10 minutes. Maximum dose generally 2 g. Maintenance infusion may be required. * **Eclampsia/Preeclampsia:** Often similar to adults, but weight-based calculations are preferred. ## Dose Adjustments * **Renal Impairment:** Magnesium is renally excreted. In patients with severe renal impairment, magnesium sulphate should be used with extreme caution and doses reduced to avoid accumulation and hypermagnesemia. Monitor serum magnesium levels closely. ## Contraindications * **Hypermagnesemia:** Known elevated serum magnesium levels. * **Heart Block:** Greater than first-degree heart block (without a pacemaker). * **Myocardial Infarction:** Acute myocardial infarction in patients with heart failure. * **Pulmonary Edema:** If related to fluid overload. * **Hypersensitivity:** Known hypersensitivity to magnesium sulphate. * **Gastrointestinal Obstruction/Perforation:** For oral formulations. ## Adverse Effects * **Common:** Flushing, sweating, nausea, vomiting, decreased reflexes, hypotension, bradycardia, somnolence. * **Serious:** Hypermagnesemia (muscle weakness, difficulty breathing, cardiac arrhythmias, cardiac arrest), respiratory depression, loss of deep tendon reflexes, coma. ## Key Drug Interactions * **Neuromuscular Blocking Agents:** Magnesium can potentiate the effects of neuromuscular blockers, potentially leading to prolonged neuromuscular blockade. * **Calcium Channel Blockers:** Additive hypotensive and cardiodepressant effects. * **Tetracyclines and Quinolones:** Magnesium can chelate these antibiotics, reducing their absorption. Separate administration by at least 2 hours. * **Digoxin:** Increased risk of digoxin toxicity if hypermagnesemia occurs. ## Monitoring * **Serum Magnesium Levels:** Crucial, especially with IV infusions and in patients with renal impairment. Target levels vary by indication. * **Renal Function:** Monitor BUN and creatinine. * **Vital Signs:** Blood pressure, heart rate, respiratory rate. * **Deep Tendon Reflexes:** Loss of reflexes is an early sign of hypermagnesemia. * **Urine Output:** Assess for adequate renal function. * **ECG:** For patients receiving IV magnesium for cardiac indications or those at risk for arrhythmias. ## Clinical Pearls * Always dilute intravenous magnesium sulphate before administration. Rapid IV injection can cause hypotension and cardiac depression. * For eclampsia, a urinary catheter should be in place to monitor output, as decreased output can indicate magnesium toxicity or a worsening condition. * Keep calcium gluconate readily available as an antidote for magnesium toxicity. * Oral magnesium sulphate can cause diarrhea; monitor fluid and electrolyte balance. *** *Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines before making treatment decisions.*